Imaging beta-amyloid in middle age alcoholics as a mechanism that increases their risk for Alzheimer’s disease

中年酗酒者中的β-淀粉样蛋白是一种增加其患阿尔茨海默病风险的机制

基本信息

项目摘要

There is a long-established relationship between alcohol use disorders, cognitive impairments, and the development of dementia. Studies have shown that heavy alcohol use in middle aged individuals impairs cognitive function even in patients who are not diagnosed with dementia (Giovanni Piumatti, 2018; Katherine Stavro, 2012). Traditionally, the study of neurocognitive impairments in alcoholics have focused on thiamine deficiency resulting in Wernicke encephalopathy or Wernicke-Korsakoff syndrome. More recently, evidence has begun to arise linking alcohol use disorders with other types of dementia including Alzheimer’s disease. Recent epidemiological data suggests that the hazard ratio to develop Alzheimer’s disease is 2-fold greater amongst individuals with alcohol use disorders compared to the general population (Michael Schwarsinger, 2018). This relationship is especially strong when alcohol abuse is examined as a risk factor for the onset of dementia in women and middle-aged adults. These epidemiological data suggest that the ‘at risk’ period to develop dementia is shifted to the middle-age years in individuals with alcohol use disorder. Consistent with this notion alcohol consuming rodents relative to controls show an increase in the expression of several proteins (such as b-amyloid precursor protein, C-terminal fragment-b, enzyme b-secretase 1, immature nicastrin, etc.,) that are involved in the synthesis of beta-amyloid plaques (Ab). However, the only post-mortem study that examined this issue in humans found no significant increase in the aggregation of Ab, hyperphosphorylated 𝜏, or 𝛼-synuclein in alcoholics compared to controls (Leena Aho, 2009). Given the retrospective nature of postmortem studies and the fact it cannot exclude co- morbid medical, psychiatric, and drug abuse disorders, it is difficult to interpret these data. There is a great need for in vivo studies to further investigate the relationship between alcohol use disorders, Ab, and Alzheimer’s disease. The positron emission tomography (PET) radiotracer [11C]PiB, which was discovered at the University of Pittsburgh is one of the most widely used and well validated Ab imaging agents (Klunk et al., 2004). Here, we propose to use [11C]PiB and PET to contrast the rate (%) of Ab positivity (+) in 40-65 year old alcoholics and controls. We hypothesize increased Ab+ in alcoholics compared to controls. Such a finding would suggest an increased risk of Ab+, and by extension explain the increased rates of Alzheimer’s dementia in alcoholics reported in recent epidemiological studies.
酒精使用障碍、认知障碍和酒精使用障碍之间存在着长期存在的关系。 痴呆症的发展。研究表明,中年人大量饮酒 即使没有被诊断患有痴呆症的患者也会损害认知功能(Giovanni Piumatti, 2018;凯瑟琳·斯塔夫罗,2012)。传统上,酗酒者神经认知障碍的研究 重点关注硫胺素缺乏导致韦尼克脑病或韦尼克-科尔萨科夫病 综合症。最近,证据开始将酒精使用障碍与其他类型联系起来 包括阿尔茨海默病在内的痴呆症。最近的流行病学数据表明,该危害 患有酒精使用障碍的人患阿尔茨海默病的比例是其两倍 与一般人群相比(Michael Schwarsinger,2018)。这种关系尤其 当酗酒被视为女性患痴呆症的一个危险因素时,这一点就很强烈 中年成年人。这些流行病学数据表明,患痴呆症的“危险期” 患有酒精使用障碍的人会转移到中年。与这个观念一致 与对照组相比,饮酒的啮齿动物显示出几种蛋白质表达的增加 (如b-淀粉样蛋白前体蛋白、C-末端片段-b、酶b-分泌酶1、未成熟的 尼卡斯特林等)参与β-淀粉样斑块(Ab)的合成。然而,唯一的 对人类这个问题进行的尸检研究发现, 与对照组相比,酗酒者中抗体、过度磷酸化 𝜏 或 𝛼-突触核蛋白的聚集(Leena 阿霍,2009)。鉴于尸检研究的回顾性以及它不能排除共同的事实 病态的医学、精神和药物滥用疾病,很难解释这些数据。有一个 非常需要体内研究来进一步研究酒精使用障碍、Ab、 和阿尔茨海默病。正电子发射断层扫描 (PET) 放射性示踪剂 [11C]PiB 匹兹堡大学发现的是最广泛使用和经过充分验证的抗体之一 显像剂(Klunk 等,2004)。在这里,我们建议使用[11C]PiB和PET来对比速率 40-65 岁酗酒者和对照者中抗体阳性 (+) 的 (%)。我们假设 Ab+ 增加 酗酒者与对照组相比。这样的发现表明 Ab+ 的风险增加,并且通过 延伸解释了最近报道的酗酒者阿尔茨海默氏痴呆症发病率的增加 流行病学研究。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

RAJESH NARENDRAN其他文献

RAJESH NARENDRAN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('RAJESH NARENDRAN', 18)}}的其他基金

PET Imaging of Cortical Dopamine Transmission in Cocaine Addiction
可卡因成瘾过程中皮质多巴胺传输的 PET 成像
  • 批准号:
    9722779
  • 财政年份:
    2018
  • 资助金额:
    $ 33.67万
  • 项目类别:
In vivo imaging of corticotropin releasing factor-nociceptin receptor interactions
促肾上腺皮质激素释放因子-伤害感受肽受体相互作用的体内成像
  • 批准号:
    9198085
  • 财政年份:
    2016
  • 资助金额:
    $ 33.67万
  • 项目类别:
PET Imaging of neurochemical transmission in cocaine use disorders
可卡因使用障碍中神经化学传递的 PET 成像
  • 批准号:
    10459233
  • 财政年份:
    2009
  • 资助金额:
    $ 33.67万
  • 项目类别:
PET Imaging of Cortical Dopamine Transmission in Cocaine Addiction
可卡因成瘾过程中皮质多巴胺传输的 PET 成像
  • 批准号:
    8118277
  • 财政年份:
    2009
  • 资助金额:
    $ 33.67万
  • 项目类别:
Imaging Cortical Dopamine Transmission in Alcohol Dependence
酒精依赖中皮质多巴胺传输的成像
  • 批准号:
    8132972
  • 财政年份:
    2009
  • 资助金额:
    $ 33.67万
  • 项目类别:
PET Imaging of Cortical Dopamine Transmission in Cocaine Addiction
可卡因成瘾过程中皮质多巴胺传输的 PET 成像
  • 批准号:
    9193064
  • 财政年份:
    2009
  • 资助金额:
    $ 33.67万
  • 项目类别:
PET Imaging of Cortical Dopamine Transmission in Cocaine Addiction
可卡因成瘾过程中皮质多巴胺传输的 PET 成像
  • 批准号:
    7790857
  • 财政年份:
    2009
  • 资助金额:
    $ 33.67万
  • 项目类别:
PET Imaging of Cortical Dopamine Transmission in Cocaine Addiction
可卡因成瘾过程中皮质多巴胺传输的 PET 成像
  • 批准号:
    7934671
  • 财政年份:
    2009
  • 资助金额:
    $ 33.67万
  • 项目类别:
PET Imaging of Cortical Dopamine Transmission in Cocaine Addiction
可卡因成瘾过程中皮质多巴胺传输的 PET 成像
  • 批准号:
    9024494
  • 财政年份:
    2009
  • 资助金额:
    $ 33.67万
  • 项目类别:
Imaging Dopamine D2 Agonist Binding Sites in Cocaine Dependence with [11C]NPA
使用 [11C]NPA 对可卡因依赖中的多巴胺 D2 激动剂结合位点进行成像
  • 批准号:
    7782808
  • 财政年份:
    2009
  • 资助金额:
    $ 33.67万
  • 项目类别:

相似海外基金

Co-designing a lifestyle, stop-vaping intervention for ex-smoking, adult vapers (CLOVER study)
为戒烟的成年电子烟使用者共同设计生活方式、戒烟干预措施(CLOVER 研究)
  • 批准号:
    MR/Z503605/1
  • 财政年份:
    2024
  • 资助金额:
    $ 33.67万
  • 项目类别:
    Research Grant
RAPID: Affective Mechanisms of Adjustment in Diverse Emerging Adult Student Communities Before, During, and Beyond the COVID-19 Pandemic
RAPID:COVID-19 大流行之前、期间和之后不同新兴成人学生社区的情感调整机制
  • 批准号:
    2402691
  • 财政年份:
    2024
  • 资助金额:
    $ 33.67万
  • 项目类别:
    Standard Grant
Early Life Antecedents Predicting Adult Daily Affective Reactivity to Stress
早期生活经历预测成人对压力的日常情感反应
  • 批准号:
    2336167
  • 财政年份:
    2024
  • 资助金额:
    $ 33.67万
  • 项目类别:
    Standard Grant
Elucidation of Adult Newt Cells Regulating the ZRS enhancer during Limb Regeneration
阐明成体蝾螈细胞在肢体再生过程中调节 ZRS 增强子
  • 批准号:
    24K12150
  • 财政年份:
    2024
  • 资助金额:
    $ 33.67万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Migrant Youth and the Sociolegal Construction of Child and Adult Categories
流动青年与儿童和成人类别的社会法律建构
  • 批准号:
    2341428
  • 财政年份:
    2024
  • 资助金额:
    $ 33.67万
  • 项目类别:
    Standard Grant
Understanding how platelets mediate new neuron formation in the adult brain
了解血小板如何介导成人大脑中新神经元的形成
  • 批准号:
    DE240100561
  • 财政年份:
    2024
  • 资助金额:
    $ 33.67万
  • 项目类别:
    Discovery Early Career Researcher Award
Laboratory testing and development of a new adult ankle splint
新型成人踝关节夹板的实验室测试和开发
  • 批准号:
    10065645
  • 财政年份:
    2023
  • 资助金额:
    $ 33.67万
  • 项目类别:
    Collaborative R&D
Usefulness of a question prompt sheet for onco-fertility in adolescent and young adult patients under 25 years old.
问题提示表对于 25 岁以下青少年和年轻成年患者的肿瘤生育力的有用性。
  • 批准号:
    23K09542
  • 财政年份:
    2023
  • 资助金额:
    $ 33.67万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Identification of new specific molecules associated with right ventricular dysfunction in adult patients with congenital heart disease
鉴定与成年先天性心脏病患者右心室功能障碍相关的新特异性分子
  • 批准号:
    23K07552
  • 财政年份:
    2023
  • 资助金额:
    $ 33.67万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Issue identifications and model developments in transitional care for patients with adult congenital heart disease.
成人先天性心脏病患者过渡护理的问题识别和模型开发。
  • 批准号:
    23K07559
  • 财政年份:
    2023
  • 资助金额:
    $ 33.67万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了